The Global Oligonucleotide Therapeutics Market estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2028, growing at a CAGR of 8% during the forecast period 2022-2028.
Oligonucleotides are short-stranded DNA or RNA, usually made using automated synthesizers. In addition, purification of oligonucleotides is accomplished by anion exchange chromatography, followed by freezing and desalting techniques. In addition, the synthesis of siRNA duplex oligonucleotides is achieved through an annealing step that brings the two purified oligonucleotide strands closer together in equimolar ratio. There are many differences between oligonucleotide therapeutics and conventional drugs. Oligonucleotide therapeutics can inhibit the expression of certain genes. This factor leads to the development of new oligonucleotides that target specific genes and treat chronic diseases. Chemically modified artificial nucleic acids are being utilized to develop these novel oligonucleotide therapeutics. The developed artificial oligonucleotide has further improved affinity for target mRNA and stability in vivo. These factors are likely to act as a growth factor for the global oligonucleotide therapeutics market.
Click Here to Get a Free Sample Report of the Oligonucleotide Therapeutics Market @ https://orionmarketreports.com/request-sample/?id=111220&submit=Request+Sample%0D%0A
Market Segments
On the basis of type
- Antisense
- Ribozymes
- Aptamers
- miRNA
- CpG/Immunostimulatory
- RNAi
On the basis of application
- Infectious diseases
- Oncology
- Neurodegenerative disorders
- Cardiovascular diseases
- Kidney diseases
Get 15% Discount on Buying this Report: https://orionmarketreports.com/request-discount/?id=111220&submit=Request+Discount
Key Players
- miRagen Therapeutics, Inc.
- Ionis Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Gilead Sciences, Inc.
- Biogen Inc.
- Regulus Therapeutics Inc.
A full report of Global Oligonucleotide Therapeutics Market is available at: https://orionmarketreports.com/oligonucleotide-therapeutics-market/111220/
Scope of the Report
The research study analyzes the global Oligonucleotide Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Oligonucleotide Therapeutics Market Report
1. What was the Oligonucleotide Therapeutics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Oligonucleotide Therapeutics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Oligonucleotide Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Oligonucleotide Therapeutics market.
- The market share of the global Oligonucleotide Therapeutics market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Oligonucleotide Therapeutics market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Oligonucleotide Therapeutics market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
